Exome Asset Management
Overview
Exome Asset Management is an innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, including pharmaceuticals, biotechnology, healthcare services, and medical devices . The firm employs soundly developed investment strategies and a philosophy tested by time . Exome practices two existing investment strategies: one which invests broadly across worldwide healthcare subsectors and geographies, and another that is a specialized healthcare investment fund emphasized on public company opportunities in emerging markets .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NexCure, Inc. | Nov 2025 | Private Placement | Lead |
| IMPACT Therapeutics | Mar 2022 | Series D | Co-investor |
| Centrexion Therapeutics | Oct 2020 | Convertible Debt | Co-investor |
For institutional investors. Book with your work email.
Key People
Sam Isaly
Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Exome Asset Management based?
Exome Asset Management is headquartered in New York City, New York, United States.
When was Exome Asset Management founded?
Exome Asset Management was founded in 2018.
How many portfolio companies does Exome Asset Management have?
Exome Asset Management has 4 portfolio companies in Caplight's dataset.
What are some companies in Exome Asset Management's portfolio?
Portfolio companies visible on Caplight include NexCure, Inc., IMPACT Therapeutics, Centrexion Therapeutics.
What was Exome Asset Management's most recent investment shown here?
Exome Asset Management's most recent investment in this portfolio sample was in NexCure, Inc. in 2025.
What sectors does Exome Asset Management focus on?
Exome Asset Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Exome Asset Management focus on?
Stage focus information for Exome Asset Management is not publicly available.
What is Exome Asset Management's AUM?
Exome Asset Management's assets under management are estimated between $100.0M and $250.0M.